Results 101 to 110 of about 13,596 (213)
Ceftazidime in severe infections: a Swiss multicentre study [PDF]
A total of 105 patients (mean age 57, range 15 to 90) with serious infections were treated with intravenous ceftazidime, usually 2 g 8-hourly. Most patients had complicating factors such as major surgery, cancer, chronic obstructive lung disease ...
Clément, M. +8 more
core
The Aetiology and Treatment Outcomes of Epididymo-Orchitis: A 2025 Clinic-Based Review
Background: Epididymo-orchitis can be caused by sexually transmitted pathogens, including Neisseria gonorrhoeae, Chlamydia trachomatis, and Mycoplasma genitalium, or entero-bacteria.
Jim Abi Frem +4 more
doaj +1 more source
On the Chemotherapeutic Effect to Tuberculous Epididymitis [PDF]
We have had histopathological observation on the e ffect of chemotherapy to tuberculous epididymitis on 10 cases. Total dosis of chemotherapeutic medicines and total number of days of medication before operation are shown on the table in p. 562.
日野, 豪, 池上, 重恵
core
Testicular Compartment Syndrome in a Case of Fulminant Necrotizing Orchitis
Testicular compartment syndrome (TCS) impedes the microcirculation in the testicle, resulting from increased venous resistance or an extraluminal compression that might lead to a cascade of hypoxia, ischemia, and gangrene.
Snehasis Das +4 more
doaj +1 more source
Acute scrotal ultrasound: a practical guide [PDF]
Antonio Fargiano +3 more
core +1 more source
We describe a case of cerebral trichomoniasis in a neonate in whom seizures and multiorgan failure developed during treatment for staphylococcal sepsis. Brain abscesses were identified with cranial sonography, and Trichomonas vaginalis was isolated from ...
core
The epidemiology of sexually transmitted infections in the United Kingdom: impact of behaviour, services and interventions [PDF]
Sexually transmitted infections (STIs) are a major public health concern. The United Kingdom (UK) has some of the most advanced STI surveillance systems globally.
Field, NM, Hughes, G
core
Clinical study of levofloxacin (DR-3355) on uro-genital infections--with special reference to usefulness for chronic prostatitis [PDF]
OFLXの一方の光学異性体であるlevofloxacinを尿路・性器感染症に1日300 mgまたは400 mgを平均12.0±0.5日間投与した.1)慢性複雑性尿路感染症(C-UTI):P. aeruginosaとP. stutzeriの2例に投与していずれも有効な成績をえた.2)慢性前立腺炎:i) 200 mg投与後, 1時間のPFの濃度は1.02±0.46 μg/ml (n=5)で, 対血清比は0.47±0.10であった.ii)慢性細菌性:7例中7例に除菌効果を認めた.iii)慢性非細菌性 ...
堀場, 優樹, 鈴木, 恵三
core

